Live feed08:30:00·19mPRReleasevia QuantisnowSilexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven CancersByQuantisnow·Wall Street's wire, on your screen.SLXN· Silexion Therapeutics CorpHealth Care
